Advertisement
Advertisement

CGTX

CGTX logo

Cognition Therapeutics, Inc. Common Stock

1.21
USD
Sponsored
+0.05
+4.31%
May 08, 15:55 UTC -4
Closed
exchange

After-Market

1.22

+0.01
+0.83%

Cognition Therapeutics, Inc. Common Stock Profile

About

Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.

Info & Links

CEO

Lisa Ricciardi

Headquarters

2500 Westchester Avenue
Purchase, NY 10577, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cogrx.com

Auditor

Ernst & Young LLP

Share holders

280

Employees

14

Cognition Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

109.01M

Enterprise Value

72.01M

Enterprise Value/EBITDA(ttm)

-1.51

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.22

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-104.27%

Return on Invested Capital(ttm)

-188.17%

Return on Assets(ttm)

-69.64%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-47.57M

Net Income Available to Common(ttm)

-23.49M

Diluted EPS(ttm)

-0.33

Share Statistics

Beta (5Y Monthly)

1.39

52-Week Change

266.67%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

89.35M

Dividend Yield

0.00%

Float4

76.49M

% Held by Insiders

14.40%

% Held by Institutions

43.35%

Balance Sheet

Total Cash(mrq)

37.00M

Total Cash Per Share(mrq)

0.41

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.45%

Quick Ratio(mrq)

3.45%

Book Value Per Share(mrq)

0.39

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.34

Free Cash Flow(ytd)

-24.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement